Skip to main content
. 2021 Oct 27;13(2):492–529. doi: 10.1093/advances/nmab119

TABLE 7.

ITF effects on appetite and satiety in healthy adults1

Ref. Study design Comparator ITF type (trade name, manufacturer) DP, range (mean) ITF dosage, g/d Intervention duration, wk Washout duration, wk N (nin ITF group) Study population characteristics Results
(27) R, DB, PC, CF No ITF Inulin (Beneo HP, DKSH/Orafti) ≥23 10 1 2 21 Adults with overweight/obesity, 60 y, BMI 25–40 ↔ Energy intake, composite appetite score, postprandial GLP-1, PYY
(119) R, SB, PC, CF Dextrin maltose Oligofructose (Raftilose P95, Beneo-Orafti) 2–7 16 2 2 10 Healthy adults age 27.2 ± 1.6 y, BMI 22.3 ± 0.7 ↑ Satiety @ breakfast and dinner (not at lunch)↓ Total energy intake; energy intake @ breakfast and dinner; hunger and prospective food consumption @ dinner
(85) R, DB, PC, P Dextrin maltose Inulin–oligofructose (Synergy 1, Beneo-Orafti) Oligofructose: 2–8 (4)Inulin: 10–60 (24) 16 2 NA 10 (5) Healthy adults age 21–38 y, BMI 21.6 ± 0.99 ↑ Postprandial GLP-1, PYY↔ Satiety, fasting GLP-1 and PYY↓ Hunger
(30) R, DB, PC, CF Cellulose Inulin (Inulin HP, Beneo-Orafti) ≥23 20 6 ≥3 (mean 6.3) 12 Nondiabetic adults with overweight/obesity, 60 ± 1 y, BMI 29.8 ± 0.9 ↔ Fasting or postprandial GLP-1, PYY
(34) R, SB, PC, CF No ITF Inulin (Inulin HP, Beneo-Orafti) ≥23 22.4 1 1 13 Healthy adults age 23 ± 4 y, BMI 22.1 ± 1.6 ↔ Energy intake, macronutrient intake, hunger, fullness, prospective food consumption, desire to eat
(35) R, SB, PC, P Cellulose + Maltodextrin Oligofructose (Beneo P95, Beneo-Orafti) 2–7 30 6 NA 22 (12) Adults with overweight/obesity, age 20–49 y, BMI 30.33 ↓ Hunger↔ Energy intake, fullness
(79) R, DB, PC, P Maltodextrin Oligofructose (Raftilose P95, Beneo-Orafti) 2–7 21 12 NA 39 (21) Adults with overweight/obesity, 40.4 y, BMI 30.1 ↑ Postprandial PYY↓ Energy intake, postprandial ghrelin and leptin↔ Postprandial GLP-1, GIP
(81) R, TB, PC, P Maltodextrin Oligofructose (Fructalose L92, Sensus) 2–10 1 wk @ 8, 11 wk @ 16 12 NA 55 (29) Adults with overweight/obesity, 41 ± 12 y, BMI 29.4 ± 2.6 ↓ Hunger, prospective food consumption↔ Energy intake
(51) R, DB, PC, P Placebo Inulin (4 g) + Oligofructose (12 g) NA 2 wk @ 8, 10 wk @ 16 12 NA 96 (26) Adults with overweight/obesity, 39.8 y, BMI 31.5 ↓ Hunger, desire to eat↔ Energy intake
(83) R, DB, PC, CF No ITF Inulin (Raftiline HP-Gel, Orafti) >23 11 5 8 20 Healthy adult men, 18.8 ± 0.7 y, BMI 22.8 ± 2.3 ↑ Neurotensin, somatostatin↓ Gastric emptying rate (∼ somatostatin [+])↔ Corticotropin releasing factor
(120) R, DB, PC, P No ITF ITF (Frutafit IQ, Sensus) 9–10 16 1 NA 36 (17) Healthy adult women, 19.7 y ↑ Fullness↓ Desire to eat, hunger, prospective food consumption, food intake at lunch
(121) R, DB, DR, PC, CF Maltodextrin Oligofructose (Fructalose L92, Sensus) 2–10 0, 10, 16 2 2 31 Healthy adults age 28 ± 3 y, BMI 24.8 ± 0.3 ↑ Postprandial GLP-1, PYY (16 g/d dose)↓ Energy intake (16 g/d dose)
(40) SGD Habitual diet ITF-rich vegetables (artichoke, garlic, salsify, shallot, leeks, scorzonera, onion, celery root) NA approx.15 2 3* 26 Healthy adults age 21.84 ± 0.39 y, BMI 22.29 ± 0.32 ↑ Satiety, desire to eat ITF-vegetables↓ Desire to eat sweet/salty/fatty food
1

CF, crossover feeding; DR, dose ranging; DB, double-blinded; DP, degree of polymerization; GIP, glucose-dependent insulinotropic peptide; GLP-1, glucagon-like peptide 1; ITF, inulin-type fructans; MCF, multiple crossover feeding; NA, not applicable; P, parallel; PC, placebo-controlled; PYY, peptide YY; R, randomized; SB, single-blinded; SC, single-center; scFOS, short-chain fructooligosaccharides; SGD, single group-design; ˜ indicates a correlation; the parentheses indicate a positive (+) or negative (−) association.